why choose us

First received: February 09, 2023

Clinical Trial: Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Locally Advanced Rectal Carcinoma

Study Type: INTERVENTIONAL


Official Title: A Prospective, Open-Label, Single-Arm and Multicentre Phase II Study to Explore the Efficacy and Safety of Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Middle and L

Brief Summary: The goal of this clinical trial is to test the efficacy and safety in patients with locally advanced middle and lower rectal cancer.The main questions it aims to answer are:• Whether Cadonilimab combined with chemotherapy following short-course radiation can improve pathological complete response(pCR) rate?•Are the toxicities of the combination therapy manageable?Participants will be given radiation of 5 Gy for 5 days and then neoadjuvant Cadonilimab combined with modified fluorouracil, leucovorin, and oxaliplatin…

Read more